ono 1078 has been researched along with Alzheimer Disease in 1 studies
pranlukast: SRS-A antagonist; leukotriene D4 receptor antagonist
Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tang, SS | 1 |
Hong, H | 1 |
Chen, L | 1 |
Mei, ZL | 1 |
Ji, MJ | 1 |
Xiang, GQ | 1 |
Li, N | 1 |
Ji, H | 1 |
1 other study available for ono 1078 and Alzheimer Disease
Article | Year |
---|---|
Involvement of cysteinyl leukotriene receptor 1 in Aβ1-42-induced neurotoxicity in vitro and in vivo.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Caspase 3; Cells, Cultured; Cerebral C | 2014 |